Heart Failure Doubles Risk of Dying From COVID-19
One expert cautions that data from the pandemic’s first-wave may not reflect the current state of treatment.
Related Articles
In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers
Compared with cold storage, the organ-preservation system helped posttransplant outcomes despite longer ischemic times.
New Heart Failure After AF Diagnosis Merits More Attention
Prevention of stroke gets highlighted by guidelines and is top-of-mind for patients, but heart failure is much more common.
BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY
Just under 50% of those treated surgically were taking no antihypertensives, all while maintaining good BP control.
AI Tools to Meet Every Need? The Future of Vascular Medicine
Already products are entering the market, and if found to improve outcomes, they may become standard of care.
Diltiazem and DOAC Interaction Increases Bleeding Risk in AF
Physicians have adopted a one-size-fits-all approach to direct oral anticoagulants that must be reconsidered, says Geoffrey Barnes.
INOCA May Be at the Root of Angina for Many Long-COVID Patients
A diagnosis can provide patients with better understanding as well as a chance to receive targeted treatment, Colin Berry says.
Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups
Investigators and others think it might be time for everybody in the US to have their Lp(a) screened at least once in a lifetime.
Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity
Top-line findings from the SURMOUNT-OSA trials may have implications for cardiometabolic risks in this population.
The MINT Trial
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.
Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter
Initial safety and efficacy findings from this first-in-human series “look really impressive,” but experts await further studies.